Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation-enhancing LPS-induced cytokine release from monocytes.
about
Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosisBasic residues in azurocidin/HBP contribute to both heparin binding and antimicrobial activityNeutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophagesTwo mutants of human heparin binding protein (CAP37): toward the understanding of the nature of lipid A/LPS and BPTI bindingStructure of HBP, a multifunctional protein with a serine proteinase foldThe role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease.Poly(ethylene glycol)-containing hydrogels promote the release of primary granules from human blood-derived polymorphonuclear leukocytesIdentification of azurocidin as a potential periodontitis biomarker by a proteomic analysis of gingival crevicular fluid.CAP37, a novel inflammatory mediator: its expression in endothelial cells and localization to atherosclerotic lesions.Neutrophil secretion products pave the way for inflammatory monocytesElevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock.Biomaterials selectively modulate interactions between human blood-derived polymorphonuclear leukocytes and monocytesNeutrophil-derived azurocidin alarms the immune system.Antimicrobial peptides: key components of the innate immune system.Neutrophil roles in left ventricular remodeling following myocardial infarction.Structure and function of the N-linked glycans of HBP/CAP37/azurocidin: crystal structure determination and biological characterization of nonglycosylated HBP.Pseudoproteases: mechanisms and function.Azurocidin-induced inhibition of oxygen metabolism in mitochondria is antagonized by heparin.Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS.Modulation of lipopolysaccharide-induced monocyte activation by heparin-binding protein and fucoidanArginine-rich cationic polypeptides amplify lipopolysaccharide-induced monocyte activationIdentifying the functional part of heparin-binding protein (HBP) as a monocyte stimulator and the novel role of monocytes as HBP producers.Influence of EDTA and heparin on lipopolysaccharide binding and cell activation, evaluated at single-cell level in whole blood.Reconstitution of human azurocidin catalytic triad and proteolytic activity by site-directed mutagenesis.Heparin-binding protein (HBP/CAP37) - a link to endothelin-1 in endotoxemia-induced pulmonary oedema?Biomaterials differentially regulate Src kinases and phosphoinositide 3-kinase-γ in polymorphonuclear leukocyte primary and tertiary granule release.The role of neutrophil granule proteins in neuroinflammation and Alzheimer's disease
P2860
Q22010613-EAC37B6C-E6EE-4013-A123-5CE30A307770Q24296762-CAF2AD96-7C7E-4BFC-A219-8EF6FC9A973FQ24652851-819E5A7C-4EEE-4453-A140-EE6B98A0BC02Q27629371-C0474F57-7620-4EF9-925E-3BC009E25586Q27735437-BF76AD8A-8257-4B43-9544-620F1A8498C1Q33949950-0FA83789-15EF-4B47-9DB0-2F1D66886620Q34000502-57F26ECB-B74F-4F0E-BC1A-2A6048DA298CQ35184073-A575BF0F-65AA-41FC-AAB3-FEE43B95B45EQ35788772-AE44B8C0-AEF7-4651-A810-AC1D44B0C5F5Q36104871-52F1163E-78D5-42FA-B1F7-870A0D463D1EQ36633615-4FD933F9-20F3-4F0B-9A9F-85DD778EE2FBQ36888306-EA403DAE-33C3-47F1-9330-133B66A08769Q37310038-6BB6365E-C980-4AEF-9E1D-AD9DC0FC8EC7Q37954721-39305205-D1BA-44F8-AD4E-C61C4A6D0981Q38111517-000EFF74-5FDE-4D7E-AA09-42BF04DA3EBAQ38318788-7737F3E8-626C-4F5F-9075-A286E6038BD6Q38458728-83DDB8DB-39D9-4ABA-8CF4-A0A02C74FF2DQ39117641-B2681A65-D4F8-4916-B770-63A1BC13B37DQ39510738-755C5B47-142F-48EA-94D1-A803EE537853Q39573997-F42BC041-80CD-47AF-9B37-A27A3B5B14CAQ39672321-9616161B-B2E0-4B07-AB81-DBDCFD5D6E65Q39750622-5CE041FE-46B5-4F9C-8929-C2E89BA64900Q44309042-39EBA3BD-FF3F-4013-A757-3D1708558BD3Q46483671-B426EC2E-CA2C-4A43-907B-5C21EEF5E75EQ52648383-209AC44C-79FE-4CFB-9A6D-4493D3B25C97Q55066431-E237AC93-7F8E-4CCA-8D0E-C5834387484EQ58701069-F4E53890-E24C-4C48-974B-7AADAFEBB13F
P2860
Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation-enhancing LPS-induced cytokine release from monocytes.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Characterization of recombinan ...... tokine release from monocytes.
@en
type
label
Characterization of recombinan ...... tokine release from monocytes.
@en
prefLabel
Characterization of recombinan ...... tokine release from monocytes.
@en
P2093
P2860
P1433
P1476
Characterization of recombinan ...... tokine release from monocytes.
@en
P2093
Flodgaard H
Nielsen PF
Rasmussen PB
P2860
P304
P356
10.1016/0014-5793(96)00639-4
P407
P577
1996-07-01T00:00:00Z